EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Potential Role and Mechanism of Cuproptosis in Osteosarcoma Treatment

Yinxi He, Ming Li

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-16

DOI: 10.2147/dddt.s657260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Yinxi He und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is a highly aggressive primary bone malignancy that predominantly affects adolescents and is characterized by invasiveness and metastasis. However, the prognosis of OS is still unsatisfactory and constrained by the limited efficacy of conventional therapies, highlighting the urgent need for novel therapeutic strategies. Recently, cuproptosis, a novel programmed cell death caused by excessive Cu accumulation in cells, has emerged as a promising avenue for OS treatment. Excessive Cu induces abnormal oligomerization of lipoylated proteins and loss of iron-sulfur cluster proteins, which is correlated with the mitochondrial tricarboxylic acid cycle, thereby resulting in proteotoxic stress and triggering cell death, especially those are highly dependent on oxidative phosphorylation. This review aims to comprehensively summarize and discuss recent advancements in targeting cuproptosis in OS, highlighting its potential as a treatment strategy. We further discuss diverse approaches, including copper ionophores, nanomedicine, and combination therapies, which could induce cuproptosis in OS. We also delved into nanomaterial-mediated cuproptosis and nanodrug delivery systems. We further explore the strategies for enhancing therapeutic specificity and synergistic cancer therapeutics, such as ferroptosis, photothermal therapy, and immunotherapy. Moreover, the connection between cuproptosis and chemoresistance in OS is involved, demonstrating its potential to overcome treatment failure. In conclusion, targeting the copper metabolism pathways, either alone or in combination with existing therapies, may offer more effective treatment options for patients with OS.

Zitieren

APA

He, Y., & Li, M. (2026). The Potential Role and Mechanism of Cuproptosis in Osteosarcoma Treatment. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s657260

Vancouver

He Y, Li M. The Potential Role and Mechanism of Cuproptosis in Osteosarcoma Treatment. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s657260

BibTeX
@article{He2026,
  author = {He, Yinxi and Li, Ming},
  title = {The Potential Role and Mechanism of Cuproptosis in Osteosarcoma Treatment},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--16},
  doi = {10.2147/dddt.s657260}
}
Kostenlos starten →